mobOx
Developer of a portable blood analysis platform for emergency and intensive care settings. The company focuses on optical sensor hardware combined with AI-based algorithms to determine blood parameters from very small sample volumes, targeting point-of-care use in emergency medical services, neonatal care and hospitals. The team is advancing prototypes toward clinical performance evaluation and holds patent-pending technology.
Industries
Nr. of Employees
small (1-50)
Products
Compact mobile blood analyzer (mobile point-of-care analyzer)
A compact, lightweight mobile analyzer designed to determine important blood parameters at the emergency site or bedside using optical sensing and AI-based algorithms. Intended for rapid decision support in emergency medicine, neonatal care and hospital transfers.
Compact mobile blood analyzer (mobile point-of-care analyzer)
A compact, lightweight mobile analyzer designed to determine important blood parameters at the emergency site or bedside using optical sensing and AI-based algorithms. Intended for rapid decision support in emergency medicine, neonatal care and hospital transfers.
Expertise Areas
- Point-of-care diagnostics for emergency and intensive care
- Optical sensor development for blood analysis
- AI/machine-learning algorithm development for diagnostic readout
- Low-volume sample diagnostics (neonatology-capable)
Key Technologies
- Optical sensing for blood analysis
- AI / machine learning for signal interpretation
- Testchip-based sample handling
- Portable point-of-care analyzer design
News & Updates
Lumeox GmbH was founded on January 9, 2024 to prepare the market launch of its first product.
Team funded by EXIST Forschungstransfer beginning May 1, 2022 to complete prototypes and carry out clinical performance evaluation.
Lumeox GmbH was founded on January 9, 2024 to prepare the market launch of its first product.
Team funded by EXIST Forschungstransfer beginning May 1, 2022 to complete prototypes and carry out clinical performance evaluation.